← Back to headlines
Medtronic's Cardiovascular and Diabetes Segments Show Strong Growth in FQ3
Medtronic's cardiovascular and diabetes divisions posted mid-teens growth in the third fiscal quarter, indicating strong performance in these key areas.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oil Jumps Above $100 After US-Iran Talks Fail
just now
Greek Joker Lottery Sees New Jackpot, €1.3 Million to Be Distributed Sunday
53m ago
Ghana Government Accused of Failing to Address Economic Challenges After Budget Review
57m ago
Hedge Fund Manager Identifies 'Generational Buying Opportunity' in TIPS
1h ago